C-RAY Therapeutics Reports Fruitful Engagements at BIO 2025, Gears Up for SNMMI Annual Meeting
June 20, 2025 – As #BIO2025 draws to a close, C-Ray Therapeutics is energized by dynamic strategic collaborations with global innovators. Key highlights from our engagements at the conference include:
-
Advancing Strategic Partnerships into Progress:
-
Advancing partnerships with 3 leading radiopharma developers across α/β-therapy platforms.
-
Exploring IIT co-development models with top European & US biotechs.
-
Building bridges with specialized investment firms driving nuclear medicine innovation.
-
Receiving strong interest in our novel target discovery platforms from incubated pioneers.
-
C-Ray Therapeutics invites you to visit us at Booth #2128 during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in New Orleans, June 21-24, 2025.
At our booth, meet with Ivy Chao, Vice President of Corporate Development, to discuss:
-
Global Licensing Opportunities (In-licensing & Out-licensing)
-
Strategic Investment Partnerships
-
IIT Co-Development Models
-
Novel Targets & PCC Libraries
Shaping the Future of Nuclear Medicine
Join us in New Orleans – where science meets jazz – to advance these promising discussions and explore breakthrough partnership opportunities in nuclear medicine.
Stay connected with C-Ray Therapeutics for the latest in nuclear medicine innovation.